Preprint · CC-BY
via OpenAlex
Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction
Jakob Woerner, Thomas M. Westbrook, Jaehyun Joo, Manu Shivakumar, Rasika Venkatesh, Tess Cherlin, Sang‐Hyuk Jung, Seokho Jeong, Damián Maseda, Michelle L. McKeague, Shwetank, Matei Ionita, Joost Wagenaar, Sarah A. Abramowitz, Anurag Verma
medRxiv · 2025 · ▲ 10 citations
Abstract
Plasma proteins capture dynamic physiological processes and may offer more immediate insight into disease risk than static genetic predictors. We evaluated the predictive utility of proteomic risk scores (ProRS) versus polygenic risk scores (PRS) across 301 phenotypes in 39,843 participants from the UK Biobank Pharma Proteomics Project. ProRS, trained on prevalent cases, were tested for incident disease and benchmarked against PRS derived from genome-wide association statistics. Among 268 phenotypes with informative signals, ProRS outperformed PRS in 88% of traits (a median C-index improvement of 9.6%), showing strongest gains for circulatory, metabolic, and immune conditions. Combined models further improved prediction, particularly for traits with higher heritability. Longitudinal analyses showed that ProRS values were elevated years before diagnosis. External validation in 841 Penn Medicine BioBank participants confirmed consistent performance and transferability, with AUC improvements up to 4.18% over PRS alone. Plasma proteomic profiling provides complementary, temporally responsive information that enhances individual-level disease prediction.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2025.07.10.25331242
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
Woerner, J., Westbrook, T.M., Joo, J., Shivakumar, M., Venkatesh, R., Cherlin, T., Jung, S., Jeong, S., Maseda, D., McKeague, M.L., Shwetank, Ionita, M., Wagenaar, J., Abramowitz, S.A., Verma, A., Zhao, B., Lee, S., Damrauer, S.M., Levin, M.G., & Heo, S. (2025). Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction. <em>medRxiv</em>. https://doi.org/10.1101/2025.07.10.25331242
Vancouver
Woerner J, Westbrook TM, Joo J, Shivakumar M, Venkatesh R, Cherlin T, et al. Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction. medRxiv. 2025. doi:10.1101/2025.07.10.25331242.
BibTeX
@unpublished{jakob2025Larges,
title = {Large-scale evaluation of proteomic and polygenic risk scores reveals complementary contributions to incident disease prediction},
author = {Jakob Woerner and Thomas M. Westbrook and Jaehyun Joo and Manu Shivakumar and Rasika Venkatesh and Tess Cherlin and Sang‐Hyuk Jung and Seokho Jeong and Damián Maseda and Michelle L. McKeague and Shwetank and Matei Ionita and Joost Wagenaar and Sarah A. Abramowitz and Anurag Verma and Bingxin Zhao and Seunggeun Lee and Scott M. Damrauer and Michael G. Levin and Su‐Jin Heo and Thomas P. Cappola and Daniel James Rader and Sharlene M. Day and Rajat Deo and Joel M. Gelfand},
journal = {medRxiv},
year = {2025},
doi = {10.1101/2025.07.10.25331242},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Obesity (Silver Spring, Md.) 2026
Open access · OA
Inflammation Associated With Obesity, Aging, and Amyloid Burden in Adults With Down Syndrome.
medRxiv 2026
Preprint · CC-BY
Self-supervised plasma proteomic representations for prospective disease prediction across varying protein availability
medRxiv 2025
Preprint · CC-BY
Predicting Alzheimer’s Disease Phenotypes With Aging Clocks: An Exploratory Analysis
Neurobehavioral Systems, Inc. 2021
Open access · US-GOV
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
medRxiv 2023
Preprint · CC-BY
Proteomic aging clock (PAC) predicts age-related outcomes in middle-aged and older adults
International journal of molecular sciences 2026
Open access · OA